Cuprina Holdings (Cayman) Limited cash flow statement CUPR

Annual Quarterly

In fiscal 2025, which ended Dec 31, 2025, Cuprina Holdings (Cayman) Limited used $7.1 million of cash from operations, down 681.5% from the year before. It spent $45,268 on capital expenditures. Free cash flow was negative, at -$7.1 million.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
Operating
Depreciation and amortization
0
-8.4%
0
Operating cash flow
-7
-681.5%
-1
Investing
Capital expenditures
0
+181.4%
0
Investing cash flow
-0
-181.4%
-0
Financing
Financing cash flow
10
+864.6%
1
Change in cash
Free cash flow
-7
-672.8%
-1
Per share
Free cash flow per share
-0.35
-579.5%
-0.05
Ratios
Free cash flow margin
-18,423.30%
-2,603.17%
Capital expenditures to revenue
116.70%
45.29%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
CUPR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Singapore, Singapore
SEC filer status
, Emerging growth company
SEC CIK
1995704

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.